Skip to main content
PepStack

TGF-Beta 1

Growth Factors
Transforming Growth Factor Beta 1TGF-β1

Overview

Transforming Growth Factor Beta 1 (TGF-β1) is an endogenous cytokine produced by various cell types, including platelets, macrophages, and fibroblasts. It belongs to the transforming growth factor beta superfamily, which is a group of proteins involved in cellular processes such as proliferation, differentiation, and apoptosis. TGF-β1 is synthesized as a precursor protein that undergoes proteolytic cleavage to become active. Researchers have extensively studied TGF-β1 due to its significant role in cellular regulation and its potential therapeutic applications. TGF-β1 plays a crucial role in regulating immune responses, wound healing, and maintaining tissue homeostasis. It is involved in the suppression of immune system activity, promoting the differentiation of regulatory T cells, and inhibiting the proliferation of T cells and natural killer cells. Additionally, TGF-β1 is a key factor in fibrosis and is implicated in the pathogenesis of various fibrotic diseases. Researchers have also explored its role in cancer biology, as it can both suppress and promote tumor growth depending on the context. TGF-β1 exerts its effects by binding to a specific receptor complex on the cell surface, which includes TGF-β receptors type I and II. Upon ligand binding, these receptors activate intracellular SMAD proteins, which translocate to the nucleus and regulate the expression of target genes. This signaling cascade is crucial for mediating the diverse biological effects of TGF-β1. The pharmacokinetic properties of TGF-β1 are not well-characterized, with limited data available on its half-life and metabolism. As an endogenous protein, its bioavailability and clearance are influenced by complex physiological processes. Clinically, TGF-β1 is not directly used as a therapeutic agent due to its pleiotropic effects and potential for adverse outcomes. However, researchers are investigating its modulation as a therapeutic strategy in conditions such as fibrosis and cancer. Regulatory agencies have not approved TGF-β1 as a drug, and its use is primarily confined to research settings.

Mechanism of Action

TGF-β1 acts on TGF-β receptors type I and II, initiating a signaling cascade involving SMAD proteins. This pathway regulates gene expression, affecting processes like cell growth, differentiation, and immune modulation.

Half-Life & Pharmacokinetics

Pharmacokinetic data for TGF-β1 is limited due to its complex endogenous regulation and rapid clearance.

Storage

Temperature

Refrigerate at 2-8°C

Light

Protect from light

Form

Aqueous solution: use within specified time after reconstitution

Notes

Ensure proper storage conditions to maintain protein stability.

Solubility

TGF-β1 is soluble in aqueous solutions, which is relevant for its formulation in research applications.

Legal Status

🇩🇪DE

Data limited

🇺🇸US

Not FDA approved as a therapeutic agent; used in research settings.

🇦🇺AU

Data limited

🇬🇧UK

Data limited

Legal status information is provided for general reference only and may not reflect the most current regulatory changes. Always verify with official government sources before making any decisions.

8 Research Publications

Transforming growth factor beta-1 (TGF-β1) expression in patients with adenomyosis.

Human

Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2024

Researchers found no significant difference in the expression of Transforming growth factor beta-1 (TGF-β1) between patients with adenomyosis and those without. The study included 49 patients who underwent hysterectomy, with 28 diagnosed with adenomyosis. Additionally, smoking did not appear to influence TGF-β1 levels in these patients.

  • No significant association between adenomyosis and TGF-β1 expression.
  • Study involved 49 patients, with 28 having adenomyosis.
  • Smoking did not affect TGF-β1 levels in women with adenomyosis.
PubMed

Direct effect of transforming growth factor-beta 1 (TGF-β1) on human apical papilla cell proliferation and mineralisation.

Unknown

Australian endodontic journal : the journal of the Australian Society of Endodontology Inc · 2022

Researchers observed that Transforming Growth Factor-beta 1 (TGF-β1) influences the growth and mineralization of human apical papilla cells. They tested various concentrations of TGF-β1 and found that it has a direct impact on these important cells involved in tooth development.

  • TGF-β1 promotes cell proliferation.
  • TGF-β1 enhances mineralization in apical papilla cells.
  • Different concentrations of TGF-β1 have varying effects.
PubMed

TGF-β

Unknown

Circulation. Arrhythmia and electrophysiology · 2017

Researchers observed that TGF-β affects the electrical properties of heart cells called myofibroblasts in neonatal rats. This suggests that TGF-β may play a role in heart function and development.

  • TGF-β influences electrical activity in heart cells.
  • The study focused on neonatal rat ventricular myofibroblasts.
  • Findings may have implications for understanding heart health.
PubMed

Roles of TGF-beta 1 signaling in the development of osteoarthritis.

Review

Histology and histopathology · 2016

Researchers observed that TGF-beta 1 (TGF-β1) plays a complex role in osteoarthritis (OA), a joint disorder that leads to cartilage and bone damage. While TGF-β1 is essential for early cartilage development, it may also contribute to joint destruction as OA progresses.

  • TGF-β1 is crucial for the formation of articular cartilage in early joint development.
  • The role of TGF-β1 in OA is conflicting, as it may also promote joint damage.
  • Understanding TGF-β1's dual roles could help clarify OA's underlying mechanisms.
PubMed

Transforming growth factor-beta 1 pathways in inflammatory airway diseases.

Review

Allergy · 2014

Researchers observed that transforming growth factor-beta 1 (TGF-β1) plays a significant role in the inflammation and immune response of airway diseases. They identified various factors, such as smoking and certain molecules, that influence TGF-β1 levels. This understanding may lead to new treatment strategies for managing these conditions.

  • TGF-β1 is involved in the remodeling and immune response of inflammatory airway diseases.
  • Factors like smoking and oxidative stress can influence TGF-β1 levels.
  • Understanding TGF-β1 regulation may help develop new treatment options.
PubMed

Polymorphisms and plasma level of transforming growth factor-Beta 1 and risk for preeclampsia: a systematic review.

Meta-Analysis

PloS one · 2014

Researchers observed that a specific genetic variation (869T>C polymorphism) in the TGF-β1 gene may lower the risk of developing preeclampsia during pregnancy. They also found that TGF-β1 levels in the blood varied between women with preeclampsia and those with normal pregnancies, but results were inconsistent across studies. More research is needed to better understand these relationships and the role of TGF-β1 in preeclampsia.

  • The TT genotype of the 869T>C polymorphism may protect against preeclampsia.
  • TGF-β1 levels were lower in the second trimester and higher in the third trimester for women with preeclampsia.
  • Current studies are limited, and further research is necessary to clarify these findings.
PubMed

MicroRNAs, transforming growth factor beta-1, and tissue fibrosis.

Review

The Journal of pathology · 2013

Researchers observed that microRNAs are important regulators of gene expression, affecting many proteins in the body. They play a significant role in diseases characterized by tissue fibrosis, particularly by influencing the activity of a key protein called TGF-β1, which is involved in scar tissue formation.

  • MicroRNAs regulate hundreds of genes and are involved in various physiological and pathological processes.
  • TGF-β1, a key protein in fibrosis, is strongly controlled by microRNAs.
  • Changes in microRNA expression can significantly alter cell behavior.
PubMed

Transforming growth factor-beta 1 and the development of vascular hypertrophy in hypertension.

Review

Blood pressure. Supplement · 1995

Researchers observed that transforming growth factor-beta 1 (TGF-beta 1) plays a crucial role in the growth of blood vessel cells, particularly in conditions of high blood pressure (hypertension). They found that TGF-beta 1 influences the growth and production of proteins in blood vessels, which can lead to thickening of the vessel walls, a condition known as vascular hypertrophy.

  • TGF-beta 1 is produced in response to various physical and chemical signals in blood vessels.
  • It affects the growth of smooth muscle cells differently in various genetic backgrounds.
  • TGF-beta 1 contributes significantly to the thickening of blood vessels in hypertension.
PubMed

Track your hormone research in PepStack

Log cycles, set reminders and visualize serum levels.

This page is for informational and research purposes only. All information is based on published scientific literature. Nothing on this page constitutes medical advice or replaces consultation with a qualified healthcare professional.